|
시장보고서
상품코드
2105006
혈관내 영상 시장 규모, 점유율, 동향 분석 : 기술별, 제품별, 용도별, 최종사용자별, 지역별 - 세계 기회 분석과 산업 예측(2026-2036년)Intravascular Imaging Market Size, Share & Trends Analysis by Technology (IVUS, OCT, NIRS, Multi-modality), Product (Catheters, Consoles, Software), Application, End User, and Geography - Global Opportunity Analysis and Industry Forecast (2026-2036) |
||||||
세계의 혈관내 영상 시장은 2026년에 13억 9,000만 달러로 추정되며, 2036년까지 28억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 연평균 성장률(CAGR)은 7.5%에 달할 것으로 전망됩니다. 본 보고서는 주요 기술, 제품, 용도, 최종사용자 및 지역에 걸친 현재의 시장 역학, 기술 발전, 임상 개발, 경쟁 전략 및 향후 성장 기회를 평가함으로써 세계 시장에 대한 종합적인 분석을 제공합니다.
혈관내 영상 기술은 혈관 내부에서 혈관의 형태, 플라크의 특성, 관강 치수 및 스텐트의 전개 상황을 실시간으로 시각화할 수 있게 함으로써, 중재적 심장학 및 혈관 의학에 혁신을 가져오고 있습니다. 기존의 혈관조영술과 달리, 혈관내 영상 기술은 고해상도의 단면 영상을 제공하여 경피적 관상동맥 중재술(PCI) 및 말초혈관 중재술에서 병변의 정확한 평가, 최적의 기기 선택, 정밀한 스텐트 크기 결정 및 시술 최적화를 지원합니다. 혈관내 초음파(IVUS), 광간섭 단층촬영(OCT), 근적외선 분광법(NIRS) 및 하이브리드 영상 플랫폼과 같은 기술은 현대의 영상 유도 심혈관 시술에서 점점 더 필수적인 요소가 되고 있습니다.
전 세계적으로 증가하는 심혈관질환의 부담, 관상동맥 질환(CAD) 및 말초동맥 질환(PAD) 유병률의 상승, 최소침습 시술의 보급 확대, 그리고 영상 유도 하 중재술을 뒷받침하는 임상적 근거의 확대가 시장 성장을 견인하는 주요 요인이 되고 있습니다. 수많은 임상 연구를 통해, 혈관내 영상 기술을 병용한 PCI는 혈관조영술을 병용한 시술에 비해 시술 정확도를 향상시키고, 심혈관계 유해 사건을 감소시키며, 스텐트 팽창을 최적화하고, 환자의 장기적 예후를 개선한다는 사실이 입증되었습니다. 의사들의 인식 제고, 긍정적인 임상 지침, 그리고 정밀 중재적 심장학의 도입 확대가 시장 성장을 지속적으로 가속화하고 있습니다.
인공지능(AI), 기계 학습, 혈관 분석 자동화, 영상 처리, 하이브리드 영상 시스템, 계산 생리학, 클라우드 기반 데이터 관리 및 카테터 공학 분야의 지속적인 발전으로 인해 혈관내 영상 기술의 역량이 현저히 향상되고 있습니다. 최신 플랫폼에서는 AI를 활용한 관강 분할, 플라크 특성 평가, 자동 스텐트 최적화, 석회화 정량화 및 실시간 시술 안내 기능이 점점 더 통합되어 진단 정확도를 높이는 동시에 시술자 간 편차와 시술 시간을 줄이고 있습니다. 카테터 검사실 정보 시스템, 심혈관 정보 시스템(CVIS), 전자건강기록(EHR)과의 통합을 통해 임상 워크플로우의 효율성이 더욱 강화되고 있습니다.
본 보고서는 주요 기술, 제품, 용도, 최종사용자 및 지역에 걸친 현재의 시장 역학, 기술 혁신, 규제 현황, 경쟁 구도 및 미래 성장 기회를 분석함으로써 전 세계 혈관내 영상 시장에 대한 종합적인 평가를 제공합니다. 본 조사에서는 주요 시장 동향, 보험 환급 동향, 투자 활동, 의사의 도입 현황, 전략적 제휴 및 업계를 선도하는 기업들이 채택하고 있는 경쟁 전략을 평가하여, 심혈관 영상 생태계 내에서 활동하는 의료기기 제조업체, 의료 제공자, 심혈관 전문의, 투자자 및 기타 이해관계자에게 실용적인 인사이트를 제공합니다.
시장 역학
혈관내 영상 시장은 심혈관질환 유병률 증가, 복잡한 관상동맥 및 말초혈관 중재술 시행 건수 증가, 최소침습적 치료 방식의 확산, 그리고 정밀 유도 하 심혈관 시술에 대한 중요성 증대로 인해 꾸준히 확대되고 있습니다. 중재 심장 전문의들은 병변 평가 정확도 향상, 스텐트 삽입 최적화, 시술에 따른 합병증 감소, 그리고 장기적인 임상 결과 개선을 도모하기 위해 혈관내 영상 진단을 점점 더 많이 활용하고 있습니다. 영상 유도 하 PCI를 뒷받침하는 근거가 축적됨에 따라, 임상 현장에서의 보다 광범위한 도입이 지속적으로 촉진되고 있습니다.
기술 혁신은 여전히 시장 성장을 좌우하는 주요 요인입니다. 최신 혈관내 영상 시스템에서는 인공지능, 자동 영상 분석, IVUS-OCT 하이브리드 플랫폼, 첨단 카테터 기술, 클라우드 컴퓨팅, 기계 학습, 정량적 영상 분석 등이 점점 더 통합되고 있습니다. 이러한 기술을 통해 관강 자동 측정, 플라크 특성 평가, 석회화 평가, 스텐트 밀착도 분석, 시술 최적화가 가능해졌으며, 동시에 시술자에 대한 의존도를 낮추고 있습니다. 카테터실 시스템, 심혈관 정보 시스템(CVIS), 병원 정보 시스템(HIS)과의 통합이 진행됨에 따라 시술 효율과 임상 워크플로가 더욱 향상되고 있습니다.
AI를 활용한 영상 진단 및 멀티모달리티 플랫폼의 급속한 진화는 시장 발전을 더욱 가속화하고 있습니다. 각 제조사들은 IVUS, OCT, NIRS와 같은 상호 보완적인 기술을 결합하여, 혈관 병변의 구조 및 구성에 대한 종합적인 평가가 가능한 영상 진단 시스템을 잇달아 도입하고 있습니다. AI 탑재 소프트웨어를 통해 혈관 직경의 자동 측정, 실시간 영상 분석 및 시술 의사결정 지원이 가능해지면서 시술의 일관성이 향상됨과 동시에, 중재의학 전문의들 사이에서 채택이 확대되고 있습니다.
큰 성장 기회가 있는 반면, 시장의 보급에는 여전히 몇 가지 요인이 영향을 미치고 있습니다. 장비 및 일회용 카테터의 높은 비용, 의료 제도별 보상액의 편차, 의사의 숙련도 곡선, 개발도상국에서의 첨단 카테터 검사실 접근 제한, 그리고 시술 비용에 대한 우려가 여전히 중요한 장벽으로 작용하고 있습니다. 의료 제공자는 또한 혈관내 영상 진단 기술의 임상적 이점을 극대화하기 위해 워크플로우 통합, 의사 교육, 그리고 영상 진단 프로토콜의 표준화에 힘써야 합니다.
그럼에도 불구하고, 이 시장은 의료기기 제조사, 의료 제공자, 심장 전문의, 그리고 의료 시스템에 큰 기회를 제공하고 있습니다. 영상 유도 PCI의 채택 확대, 말초혈관 중재술의 확대, 카테터 검사실 현대화에 대한 투자 증가, AI를 활용한 영상 분석의 도입 확대, 그리고 하이브리드 영상 기술 분야의 지속적인 혁신이 시장의 지속적인 성장을 뒷받침할 것으로 예상됩니다. 의료기기 제조사, 병원, 학술 기관, 심혈관 학회 및 기술 개발자 간의 전략적 제휴를 통해 혈관내 영상 분야의 전체 생태계에서 제품 혁신, 임상 연구, 의사 교육 및 상용화가 가속화되고 있습니다.
부문 분석
본 보고서는 기술, 제품, 용도, 최종사용자, 지역별로 혈관내 영상 시장을 상세히 분석하여, 이해관계자들이 고성장 부문과 새로운 투자 기회를 파악할 수 있도록 지원합니다.
기술별로는 혈관내 초음파(IVUS), 광간섭 단층촬영(OCT), 근적외선 분광법(NIRS) 및 다중 모달리티 영상 기술에 대한 시장 분석을 수행하고 있습니다.
혈관내 초음파(IVUS)는 임상 현장에서의 광범위한 채택, 풍부한 근거, 그리고 관상동맥 및 말초혈관 중재술 중 혈관 치수, 플라크 부하, 관강 크기, 스텐트 팽창을 정확하게 평가할 수 있는 능력 덕분에 시장에서 가장 큰 점유율을 차지하고 있습니다. IVUS는 경피적 관상동맥 중재술(PCI)의 최적화, 시술 정밀도 향상, 재협착 감소, 그리고 복잡한 관상동맥 병변의 치료 지원을 위해 점점 더 많이 활용되고 있습니다.
광간섭단층촬영(OCT)은 초고해상도 영상화 능력을 통해 혈관의 미세 구조, 플라크 형태, 스텐트 스트럿의 밀착도, 조직 피복 및 시술 결과를 상세하게 시각화할 수 있어, 예측 기간 동안 가장 빠른 성장이 예상됩니다. OCT 유도 PCI에 대한 의료진의 선호도 증가와 지속적인 기술 발전이 시장 내 보급을 가속화하고 있습니다.
근적외선 분광법(NIRS)은 지질이 풍부한 플라크를 식별하고 플라크의 구성을 평가할 수 있어 심혈관 위험 평가 및 치료 계획 수립을 지원함으로써 계속해서 주목받고 있습니다. 또한, 임상의들이 단일 시술 내에서 혈관의 구조 및 조성에 대한 종합적인 평가를 요구하는 경향이 강해지고 있어, IVUS, OCT, NIRS를 통합한 다중 모달리티 영상 진단 플랫폼 역시 상당한 성장이 예상됩니다.
목차
제1장 시장 정의와 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 인사이트
제5장 세계의 혈관내 영상 시장 : 기술별
제6장 세계의 혈관내 영상 시장 : 제품 구성요소별
제7장 세계의 혈관내 영상 시장 : 용도별
제8장 세계의 혈관내 영상 시장 : 최종사용자별
제9장 세계의 혈관내 영상 시장 : 지역별
제10장 경쟁 구도
제11장 기업 개요
제12장 부록
KSM 26.08.11The global Intravascular Imaging Market is estimated to be valued at USD 1.39 billion in 2026 and is projected to reach USD 2.85 billion by 2036, registering a CAGR of 7.5% during the forecast period. The report provides a comprehensive assessment of the global market by evaluating current industry dynamics, technological advancements, clinical developments, competitive strategies, and future growth opportunities across major technologies, products, applications, end users, and geographic regions.
Intravascular imaging technologies are transforming interventional cardiology and vascular medicine by enabling real-time visualization of vessel morphology, plaque characteristics, lumen dimensions, and stent deployment from within blood vessels. Unlike conventional angiography, intravascular imaging provides high-resolution cross-sectional images that support accurate lesion assessment, optimal device selection, precise stent sizing, and procedural optimization during percutaneous coronary intervention (PCI) and peripheral vascular interventions. Technologies such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), and hybrid imaging platforms are increasingly becoming integral components of modern image-guided cardiovascular procedures.
The increasing global burden of cardiovascular diseases, rising prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD), growing adoption of minimally invasive procedures, and expanding clinical evidence supporting imaging-guided interventions are major factors driving market growth. Numerous clinical studies have demonstrated that intravascular imaging-guided PCI improves procedural precision, reduces adverse cardiovascular events, optimizes stent expansion, and enhances long-term patient outcomes compared with angiography-guided interventions. Growing physician awareness, favorable clinical guidelines, and increasing adoption of precision interventional cardiology continue to accelerate market expansion.
Continuous advancements in artificial intelligence (AI), machine learning, automated vessel analysis, image processing, hybrid imaging systems, computational physiology, cloud-based data management, and catheter engineering are significantly enhancing intravascular imaging capabilities. Modern platforms increasingly integrate AI-powered lumen segmentation, plaque characterization, automated stent optimization, calcification quantification, and real-time procedural guidance to improve diagnostic accuracy while reducing operator variability and procedure time. Integration with catheterization laboratory information systems, cardiovascular information systems (CVIS), and electronic health records (EHRs) further strengthens clinical workflow efficiency.
This report provides a comprehensive assessment of the global intravascular imaging market by analyzing current industry dynamics, technological innovations, regulatory developments, competitive landscape, and future growth opportunities across major technologies, products, applications, end users, and geographic regions. The study evaluates key market trends, reimbursement developments, investment activities, physician adoption patterns, strategic collaborations, and competitive strategies adopted by leading industry participants to provide actionable insights for medical device manufacturers, healthcare providers, cardiovascular specialists, investors, and other stakeholders operating within the cardiovascular imaging ecosystem.
Market Dynamics
The intravascular imaging market is expanding steadily due to the increasing prevalence of cardiovascular diseases, growing volume of complex coronary and peripheral interventions, rising adoption of minimally invasive treatment approaches, and increasing emphasis on precision-guided cardiovascular procedures. Interventional cardiologists are increasingly utilizing intravascular imaging to improve lesion assessment, optimize stent deployment, reduce procedural complications, and improve long-term clinical outcomes. The growing body of evidence supporting imaging-guided PCI continues to encourage wider clinical adoption.
Technological innovation remains a major factor shaping market growth. Modern intravascular imaging systems increasingly integrate artificial intelligence, automated image interpretation, hybrid IVUS-OCT platforms, advanced catheter technologies, cloud computing, machine learning, and quantitative image analysis. These technologies enable automated lumen measurements, plaque characterization, calcification assessment, stent apposition analysis, and procedural optimization while reducing operator dependence. Increasing integration with catheterization laboratory systems, cardiovascular information systems (CVIS), and hospital information systems (HIS) further improves procedural efficiency and clinical workflow.
The rapid evolution of AI-assisted imaging and multi-modality platforms is further accelerating market development. Manufacturers are increasingly introducing imaging systems that combine complementary technologies such as IVUS, OCT, and NIRS to provide comprehensive structural and compositional assessment of vascular lesions. AI-powered software enables automated vessel sizing, real-time image analysis, and procedural decision support, improving procedural consistency and expanding adoption among interventional physicians.
Despite strong growth opportunities, several factors continue to influence market adoption. High equipment and disposable catheter costs, reimbursement variability across healthcare systems, physician learning curves, limited access to advanced catheterization laboratories in developing countries, and procedural cost considerations remain important barriers. Healthcare providers must also address workflow integration, physician training, and standardization of imaging protocols to maximize the clinical benefits of intravascular imaging technologies.
The market nevertheless presents substantial opportunities for medical device manufacturers, healthcare providers, cardiovascular specialists, and healthcare systems. Increasing adoption of imaging-guided PCI, expanding peripheral vascular interventions, growing investments in catheterization laboratory modernization, rising implementation of AI-assisted image analysis, and continuous innovation in hybrid imaging technologies are expected to support sustained market growth. Strategic collaborations among medical device companies, hospitals, academic institutions, cardiovascular societies, and technology developers are accelerating product innovation, clinical research, physician education, and commercialization across the intravascular imaging ecosystem.
Segment Analysis
The report provides an extensive analysis of the intravascular imaging market across technology, product, application, end user, and geography, enabling stakeholders to identify high-growth segments and emerging investment opportunities.
Based on technology, the market is analyzed across intravascular ultrasound (IVUS), optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), and multi-modality imaging.
Intravascular ultrasound (IVUS) accounts for the largest share of the market owing to its widespread clinical adoption, extensive evidence base, and ability to accurately assess vessel dimensions, plaque burden, lumen size, and stent expansion during coronary and peripheral interventions. IVUS is increasingly utilized to optimize percutaneous coronary interventions (PCI), improve procedural precision, reduce restenosis, and support treatment of complex coronary lesions.
Optical coherence tomography (OCT) is expected to witness the fastest growth during the forecast period due to its ultra-high-resolution imaging capability, enabling detailed visualization of vessel microstructures, plaque morphology, stent strut apposition, tissue coverage, and procedural outcomes. Growing physician preference for OCT-guided PCI and continuous technological advancements are accelerating market adoption.
Near-infrared spectroscopy (NIRS) continues to gain traction owing to its ability to identify lipid-rich plaques and assess plaque composition, thereby supporting cardiovascular risk assessment and treatment planning. Multi-modality imaging platforms that integrate IVUS, OCT, and NIRS are also expected to experience significant growth as clinicians increasingly seek comprehensive structural and compositional vascular assessment within a single procedure.
Based on product, the market is segmented into catheters, consoles, and software.
Catheters represent the largest product segment owing to their recurring utilization during every intravascular imaging procedure. Increasing procedural volumes, technological advancements in catheter design, improved flexibility, enhanced imaging quality, and compatibility with advanced imaging consoles continue to drive demand.
Consoles are witnessing steady growth due to increasing installation of next-generation imaging platforms equipped with artificial intelligence, automated vessel analysis, high-speed image processing, and integrated procedural guidance capabilities. Modern consoles improve workflow efficiency and support more accurate clinical decision-making.
Software is expected to register robust growth owing to increasing implementation of artificial intelligence-powered image analysis, automated lumen segmentation, plaque characterization, quantitative vascular analysis, procedural planning, and cloud-based image management solutions. Advanced software platforms improve diagnostic accuracy while reducing operator variability and interpretation time.
Based on application, the market is evaluated across coronary interventions and peripheral interventions.
Coronary interventions account for the largest share of the market owing to the increasing prevalence of coronary artery disease (CAD), growing volumes of percutaneous coronary intervention (PCI), and expanding clinical evidence supporting intravascular imaging-guided stent implantation. Intravascular imaging enables accurate lesion characterization, optimal stent sizing, appropriate stent expansion, and improved long-term cardiovascular outcomes.
Peripheral interventions are expected to witness significant growth during the forecast period due to increasing prevalence of peripheral artery disease (PAD), rising adoption of minimally invasive vascular procedures, and expanding use of intravascular imaging in lower extremity, carotid, and other peripheral vascular interventions. Advanced imaging supports lesion assessment, vessel sizing, plaque characterization, and optimization of endovascular procedures.
Based on end user, the market is segmented into hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and other end users.
Hospitals continue to account for the largest market share owing to the availability of advanced cardiovascular departments, experienced interventional cardiologists, comprehensive catheterization laboratory infrastructure, and increasing adoption of image-guided interventions. Large tertiary hospitals continue to invest in advanced intravascular imaging technologies to improve procedural outcomes and expand complex cardiovascular intervention capabilities.
Cardiac catheterization laboratories are expected to witness substantial growth due to increasing procedure volumes, growing implementation of advanced imaging systems, and expanding adoption of AI-assisted procedural guidance. Ambulatory surgical centers (ASCs) are also gradually increasing utilization of intravascular imaging technologies as minimally invasive cardiovascular procedures continue to shift toward outpatient settings.
Regional Analysis
The report offers a comprehensive assessment of market performance across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each regional analysis considers cardiovascular disease burden, healthcare infrastructure, catheterization laboratory capacity, reimbursement environment, regulatory landscape, physician adoption, and competitive intensity to provide a holistic understanding of regional growth dynamics.
North America currently represents the largest share of the global intravascular imaging market owing to its advanced cardiovascular healthcare infrastructure, high adoption of image-guided interventions, favorable reimbursement environment, increasing prevalence of coronary artery disease, and strong presence of leading medical device manufacturers. Growing physician awareness, expanding clinical evidence, and continuous technological innovation continue to strengthen regional market leadership.
Europe demonstrates strong market growth supported by increasing adoption of intravascular imaging-guided PCI, expanding clinical guideline recommendations, growing investments in catheterization laboratory modernization, and rising demand for precision cardiovascular care. Continuous research activities and favorable healthcare policies are further supporting regional adoption.
Asia-Pacific is expected to register the fastest growth during the forecast period due to rapidly increasing cardiovascular disease prevalence, expanding healthcare infrastructure, growing volumes of coronary interventions, rising healthcare expenditure, and increasing investments in advanced cardiovascular imaging technologies across China, Japan, India, South Korea, Australia, and Southeast Asian countries. Improving physician training and increasing availability of advanced catheterization laboratories continue to create substantial market opportunities.
Latin America and the Middle East & Africa are also expected to present attractive growth opportunities as healthcare systems continue to modernize, cardiovascular disease awareness increases, and access to advanced interventional cardiology technologies expands. Rising investments in cardiovascular care, improving healthcare infrastructure, and growing adoption of minimally invasive procedures are expected to support market growth across these emerging regions.
Competitive Landscape
The report presents a detailed evaluation of the competitive landscape, offering valuable insights into the strategic positioning of major industry participants. It examines company portfolios, business strategies, technological capabilities, product launches, regulatory approvals, mergers and acquisitions, partnerships, collaborations, geographic expansion initiatives, research and development investments, and other significant corporate developments shaping the competitive environment.
Company benchmarking enables stakeholders to compare market participants based on their intravascular imaging technology portfolios, imaging catheter offerings, console platforms, software capabilities, artificial intelligence expertise, clinical evidence, geographic presence, innovation pipelines, and competitive strengths. The report also evaluates the evolving competitive intensity resulting from continuous advancements in intravascular ultrasound (IVUS), optical coherence tomography (OCT), near-infrared spectroscopy (NIRS), hybrid imaging technologies, artificial intelligence, machine learning, computational image analysis, cloud-based data management, and image-guided cardiovascular interventions, along with increasing investments in precision interventional cardiology.
As healthcare providers increasingly prioritize precision-guided cardiovascular interventions, minimally invasive procedures, and improved long-term patient outcomes, market participants are focusing on developing integrated intravascular imaging ecosystems that combine advanced imaging catheters, AI-powered image analysis, automated vessel sizing, plaque characterization, procedural guidance software, cloud-enabled workflow management, and next-generation imaging consoles. These technologies enable physicians to optimize lesion assessment, improve stent selection and deployment, reduce procedural complications, and enhance clinical decision-making during coronary and peripheral vascular interventions.
Continuous innovation aimed at improving imaging resolution, catheter flexibility, procedural efficiency, artificial intelligence-assisted interpretation, workflow integration, interoperability, cybersecurity, scalability, and integration with cardiovascular information systems (CVIS), catheterization laboratory platforms, hospital information systems (HIS), electronic health records (EHRs), and hemodynamic monitoring systems is expected to strengthen competitive differentiation across the market. Leading companies are also strengthening their global market presence through strategic collaborations with hospitals, cardiovascular centers, academic institutions, physician societies, and research organizations while investing in product innovation, clinical trials, physician education, regulatory approvals, and geographic expansion.
Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Terumo Corporation, Infraredx, Inc. (Nipro Corporation), ACIST Medical Systems, Inc. (Bracco Imaging S.p.A.), Conavi Medical Corp., Siemens Healthineers AG, Canon Medical Systems Corporation, and Shenzhen Heartcare Medical Technology Co., Ltd.
How This Report Helps
- Provides reliable market size estimates and long-term growth forecasts.
- Evaluates major market drivers, restraints, opportunities, challenges, and emerging industry trends.
- Identifies high-growth technology, product, application, end-user, and regional segments.
- Assesses evolving technology adoption and innovation across the intravascular imaging ecosystem.
- Benchmarks leading companies based on their product portfolios, strategic initiatives, technological capabilities, clinical evidence, and competitive positioning.
- Supports business expansion, investment planning, partnership evaluation, cardiovascular imaging adoption, catheterization laboratory modernization, and product development initiatives.
- Delivers actionable insights for medical device manufacturers, hospitals, cardiovascular centers, interventional cardiologists, investors, consultants, and other industry stakeholders.
Key Questions Answered
- What is the current size of the global intravascular imaging market, and what is its projected growth through 2036?
- Which factors are driving, restraining, and influencing market growth?
- What opportunities and challenges are expected to shape the industry during the forecast period?
- Which technology, product, application, end-user, and regional segments are expected to witness the strongest growth?
- Which regions are expected to offer the most attractive business opportunities?
- Who are the leading companies operating in the market, and how are they strengthening their competitive positions?
- What recent technological developments, product launches, regulatory approvals, partnerships, mergers and acquisitions, and strategic initiatives are influencing the competitive landscape?
- How can stakeholders leverage market intelligence from this report to support strategic planning, investment decisions, image-guided cardiovascular interventions, catheterization laboratory optimization, and next-generation intravascular imaging product development?
TABLE OF CONTENTS
1. Market Definition & Scope
- 1.1. Market Definition
- 1.2. Market Ecosystem
- 1.3. Currency Considered
- 1.4. Key Stakeholders
2. Research Methodology
- 2.1. Research Approach
- 2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders
- 2.3. Market Sizing and Forecast
- 2.3.1. Market Size Estimation Approach
- 2.3.1.1. Bottom-Up Approach
- 2.3.1.2. Top-Down Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Assumptions for the Study
- 2.3.1. Market Size Estimation Approach
3. Executive Summary
- 3.1. Overview
- 3.2. Segmental Analysis
- 3.2.1. Market Analysis, by Technology
- 3.2.2. Market Analysis, by Product Component
- 3.2.3. Market Analysis, by Application
- 3.2.4. Market Analysis, by End User
- 3.2.5. Market Analysis, by Geography
- 3.3. Competitive Analysis
4. Market Insights
- 4.1. Overview
- 4.2. Factors Affecting Market Growth
- 4.2.1. Drivers
- 4.2.1.1. Growing Volume of Complex PCIs and Calcified Lesions
- 4.2.1.2. Strong Clinical Evidence Supporting Imaging-Guided PCI (Stats: 38% TVF Reduction)
- 4.2.1.3. Integration of AI-Powered Automated Vessel Analysis Tools
- 4.2.2. Restraints
- 4.2.2.1. High Procedural Costs and Reimbursement Disparities
- 4.2.2.2. Technical Learning Curve and Procedural Efficiency Concerns
- 4.2.3. Opportunities
- 4.2.3.1. Expansion into Peripheral Vascular Interventions for PAD
- 4.2.3.2. Development of Cloud-Based Tele-proctoring and Remote Assistance
- 4.2.4. Challenges
- 4.2.4.1. Managing Cybersecurity and Data Privacy in Connected Consoles
- 4.2.4.2. Competition Between IVUS and OCT Modalities
- 4.2.5. Trends
- 4.2.5.1. Shift Toward Software-Defined, Multi-Modality Imaging Platforms
- 4.2.5.2. Rise of Real-Time AI-Guided Procedural Optimization
- 4.2.1. Drivers
- 4.3. Porter's Five Forces Analysis
- 4.4. Regulatory Landscape
- 4.5. Value Chain Analysis
5. Global Intravascular Imaging Market, by Technology
- 5.1. Overview
- 5.2. Intravascular Ultrasound (IVUS)
- 5.2.1. Rotational IVUS
- 5.2.2. Solid-State (Phased-Array) IVUS
- 5.3. Optical Coherence Tomography (OCT)
- 5.4. Near-Infrared Spectroscopy (NIRS)
- 5.5. Multi-Modality Imaging Systems
6. Global Intravascular Imaging Market, by Product Component
- 6.1. Overview
- 6.2. Imaging Catheters (Disposables)
- 6.2.1. Coronary Catheters
- 6.2.2. Peripheral Catheters
- 6.3. Imaging Consoles & Hardware
- 6.4. Software & AI Modules
7. Global Intravascular Imaging Market, by Application
- 7.1. Overview
- 7.2. Coronary Interventions
- 7.2.1. Complex PCI & CTO
- 7.2.2. Left Main Intervention
- 7.3. Peripheral Interventions
- 7.3.1. Carotid Imaging
- 7.3.2. Iliofemoral & Popliteal Imaging
8. Global Intravascular Imaging Market, by End User
- 8.1. Overview
- 8.2. Hospitals & Cardiac Catheterization Labs
- 8.3. Ambulatory Surgical Centers (ASCs)
- 8.4. Academic & Research Institutes
9. Global Intravascular Imaging Market, by Geography
- 9.1. Overview
- 9.2. North America
- 9.2.1. U.S. (Stats: ~40% Global Market Share)
- 9.2.2. Canada
- 9.3. Europe
- 9.3.1. Germany
- 9.3.2. France
- 9.3.3. U.K.
- 9.3.4. Italy
- 9.3.5. Spain
- 9.3.6. Rest of Europe
- 9.4. Asia-Pacific
- 9.4.1. Japan (Stats: >80% PCI Imaging Adoption)
- 9.4.2. China
- 9.4.3. India
- 9.4.4. Australia
- 9.4.5. Rest of Asia-Pacific
- 9.5. Latin America
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 9.6. Middle East & Africa
10. Competitive Landscape
- 10.1. Overview
- 10.2. Key Growth Strategies
- 10.3. Competitive Dashboard
- 10.4. Vendor Market Positioning
- 10.5. Market Share Analysis, 2025
11. Company Profiles
- 11.1. Abbott Laboratories
- 11.2. Boston Scientific Corporation
- 11.3. Royal Philips (Philips Healthcare)
- 11.4. Terumo Corporation
- 11.5. Infraredx, Inc. (Nipro Corporation)
- 11.6. ACIST Medical Systems (Bracco Group)
- 11.7. Conavi Medical Inc.
- 11.8. Gentuity, LLC
- 11.9. Axle International
- 11.10. Insight Guided Systems
- 11.11. Avinger, Inc.
- 11.12. Silicon Valley Medical Instruments
- 11.13. Pulse Medical Imaging Technology (Shanghai) Co., Ltd.
- 11.14. Lepu Medical Technology (Beijing) Co., Ltd.
- 11.15. MicroPort Scientific Corporation
- 11.16. APT Medical Inc.
